Watch FIFA World Cup 2026™

LIVE, FREE and EXCLUSIVE

New treatments for dementia in a decade

A leading British scientists says new treatments for dementia are in the pipeline with therapies being trialled which could provide a breakthrough.

New treatments for dementia are "on target" to be developed within the next decade, a leading expert has said.

Researchers will know if they are at the beginning of "a new era" for tackling the development of diseases such as Alzheimer's "in the coming year", Professor John Hardy said.

The award-winning University College London biologist says therapies being trialled which combat the build-up of the damaging amyloid beta and tau protein concentrations in the brain could provide a breakthrough.

Speaking at the Royal Society, London, he said: "I think we are on target for some therapies for 2025. When the drug trial results come out - and if they're positive - we will know we are on the right road.

"When you are on the right road, you put your foot on the accelerator and you can go quicker, so those results are key."

News that makes sense

Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

"In the coming year we will know if we are already at the start of a new era of better treatments for slowing or stopping the development of Alzheimer's disease and allied neurodegenerative disorders, or if current research strategies should be refocused."

Dementia is a degenerative disorder and its symptoms include memory loss.

Age is the main risk factor, but not the cause, for dementia.

As well as Alzheimer's, understanding of other forms of dementia such as Parkinson's disease is also progressing, Professor Hardy said.

Symptoms of dementia are believed to sometimes be caused when amyloid beta clumps together to form a plaque in the brain, interfering with how brain cells signal to each other.

Some of the current drug trials focus on using antibodies to take amyloid beta out of the brain.

If successful, these drugs could be used to prevent the development of dementia in its early stages.

Research also determined that Parkinson's disease can be caused by a set of genes which control how the brain digests its proteins.

As well as pharmaceutical treatments for dementia, experts also stress the importance of lifestyle improvements in preventing a disorder from developing.

Smoking, high cholesterol, drinking above recommended limits and high blood pressure are identified as factors which raise the risk of developing such a disease, according to Public Health England.


3 min read

Published

Updated

Source: AAP



Share this with family and friends


Get SBS News straight to your inbox

Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Follow SBS News

Download our apps

Listen to our podcasts

Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS

SBS World News

Take a global view with Australia's most comprehensive world news service

Stream now

Watch the latest news videos from Australia and across the world